Department of TB and Chest Diseases

On Going Research Projects

Dept. data last updated on :06/01/2024

Project Title :

Effect of COVID -19 vaccine on thrombotic events among 18-45 years-old population in India, 2022, under the COVID-19 registry"


Funding Agency :

ICMR

Funding Amount :

168700

Principal Investigator :

Prof. Mohammad Shameem

Co- Principal Investigator :

Project Title :

Covaxine clinical trial 

Funding Agency :

ICMR

Funding Amount :

10000000

Principal Investigator :

Prof Mohammad Shameem

Co- Principal Investigator :

Prof. Tarique Mansoor

Project Title :

Randomised evaluation of COVID-19 THERAPY(RECOVERY Trial)



Funding Agency :

ICMR

Funding Amount :

297997

Principal Investigator :

Prof .Mohammad Shameem

Co- Principal Investigator :

Project Title :

Factors associated with sudden deaths among adults aged 18-45 years, India: Multicentric matched case-control study


Funding Agency :

ICMR

Funding Amount :

320185

Principal Investigator :

Prof. Mohammad Shameem

Co- Principal Investigator :

Project Title :

Oberon Study


Funding Agency :

GLOBAL

Funding Amount :

100000

Principal Investigator :

Prof. Mohammad Shameem

Co- Principal Investigator :

Project Title :

KALOS STUDY

Funding Agency :

GLOBAL

Funding Amount :

150000

Principal Investigator :

Prof. Mohammad Shameem

Co- Principal Investigator :

Project Title :

SUNRISE TRIAL

Funding Agency :

GLOBAL

Funding Amount :

1000000

Principal Investigator :

Prof. Mohammad Shameem

Co- Principal Investigator :

Project Title :

National Covid -19 Registry


Funding Agency :

ICMR

Funding Amount :

1222000

Principal Investigator :

Prof. Mohammad Shameem

Co- Principal Investigator :

Project Title :

National clinical registry of COVID-19

Funding Agency :

ICMR

Funding Amount :

1300000

Principal Investigator :

Prof Mohammad Shameem

Co- Principal Investigator :

Dr Nazish Fatima, Dr Nafees Ahmad Khan

Project Title :

Risk Factor Associated with Mucor Mycosis - A Multi centric Case Control Study

Funding Agency :

ICMR

Funding Amount :

440000

Principal Investigator :

Prof Mohammad Shameem

Co- Principal Investigator :

Dr Nazish Fatima; Dr Aftab Ahmed

Project Title :

RESPIRE - A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Clinical Trial to Evaluate the Safety and Efficacy of ATR-002 in Adult Hospitalized Patients with COVID-19

Funding Agency :

GmBh Germany

Funding Amount :

100000

Principal Investigator :

Prof Mohammad Shameem

Co- Principal Investigator :

Dr Shahzad Anwar

Project Title :

A phase 2 multi-center -Open label , Single -Arm trial investigating the safety and Pharmacokinetics of C21 in subjects of idiopathic pulmonary fibrosis.

Funding Agency :

Vicore Pharma AB

Funding Amount :

Principal Investigator :

Prof Zuber Ahmed

Co- Principal Investigator :

Dr Ummul Baneen

Project Title :

A Multi-Centre, Prospective, Open Label, Parallel, Randomized, Clinical Trial to Assess the Efficacy And Safety Of Molnupiravir 800 Mg Capsules And Standard of Care (SoC) Compared To Standard of Care (SoC) Only In Mild Patients With Polymerase Chain Reaction (PCR) Confirmed COVID-19


Funding Agency :

GDD

Funding Amount :

500000

Principal Investigator :

Prof Mohammad Shameem

Co- Principal Investigator :